
    
      The objective of the study is to verify the safety and efficacy of the MDT-4107 Drug-Eluting
      Coronary Stent in the treatment of de novo lesions in native coronary arteries with a
      reference vessel diameter (RVD) that allows the use of 2.25mm diameter stents.
    
  